Gallstones and biliary diseases

Primary Care - Clinics in Office Practice

Volumn 28, Issue 3, 2001, Pages 591-606

  Kalloo, Anthony N ^a   Kantsevoy, Sergey V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CEFTRIAXONE; CISAPRIDE; ERYTHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; OCTREOTIDE; PROTON PUMP INHIBITOR;

ACUTE CHOLECYSTITIS; ACUTE PANCREATITIS; BILIARY TRACT DISEASE; CHOLECYSTECTOMY; CLINICAL FEATURE; CLINICAL TRIAL; COMMON BILE DUCT STONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GALLSTONE; HUMAN; LAPAROSCOPIC SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; ACUTE DISEASE; CHOLELITHIASIS; CHRONIC DISEASE; GENERAL PRACTICE; METHODOLOGY; PATIENT REFERRAL; PRIMARY HEALTH CARE; RISK FACTOR;

ACUTE DISEASE; BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLELITHIASIS; CHRONIC DISEASE; FAMILY PRACTICE; HUMANS; MAGNETIC RESONANCE IMAGING; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034811622     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(05)70055-5     Document Type: Article

References (82)

1. Identification of human biliary alpha 1-acid glycoprotein as a cholesterol crystallization promoter
2. Gallstone migration as a cause of acute pancreatitis
3. Etiology and pathogenesis of acute biliary pancreatitis
4. Management of gallstones and their complications
5. If I had a retained common bile duct stone
6. Acute and chronic pancreatitis
7. Gallstone disease and its complications
8. Intensified ESWL of gallstones: Dissociation of pulverisation, pain relief and stone-clearance
9. Physical-chemical pathogenesis of pigment gallstones
10. Gallstone recurrence after successful shock wave therapy: The magnitude of the problem and the predictive factors
11. Fibronectin: A possible factor promoting cholesterol monohydrate crystallization in bile
12. Endoscopic sphincterotomy for stones by experts is safe, even in younger patients with normal ducts
13. Evolving management of biliary tract disease
14. Pathogenesis and management of choledocholithiasis
15. Extracorporeal shockwave lithotripsy of gallstones: Clinical experience with 170 patients
16. Physical and metabolic factors in gallstone pathogenesis
17. Cholecystectomy by coelioscopy
18. In vitro investigation of the origin of echoes with biliary sludge
19. Biliary pancreatitis: A review. Emphasizing appropriate endoscopic intervention
20. Complications of endoscopic biliary sphincterotomy
21. Natural history of asymptomatic and symptomatic gallstones
22. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study
23. Cholelithiasis and cholecystitis
24. Endoscopic management of benign pancreatic disease
25. Detection of gall stones after acute pancreatitis
26. The natural history of silent gallstones: The innocent gallstone is not a myth
27. Cholesterol nucleation-influencing activity in T-tube bile
28. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis
29. Ambulatory surgery in the United States, 1996
30. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones
31. Surgery for acute and chronic cholecystitis
32. Predicting common bile duct lithiasis: Determination and prospective validation of a model predicting low risk
33. Nonsurgical management of gallstone disease
34. Digestive disease as a national problem, V: Gallstones
35. Antibiotic prophylaxis in severe acute pancreatitis
36. Biliary diseases
37. Treatment of high-risk patients with symptomatic cholelithiasis by endoscopic gallbladder stenting
38. Gallstone formation. Local factors
39. Biliary sludge
40. Balloon dilation of the sphincter of Oddi
41. Laparoscopic cholecystectomy for acute cholecystitis: Is it really safe?
42. 1997 Summary: National Hospital Discharge Survey
43. Choledocholithiasis, bacterial cholangitis, oriental intrahepatic stone disease, and parasitic disorders of the biliary tree
44. Successes, failures, early complications and their management following endoscopic sphincterotomy: Results in 394 consecutive patients from a single centre
45. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis
46. Magnetic resonance-cholangiopancreatography in the diagnosis of biliopancreatic diseases
47. Quantitative infrared spectroscopy of common bile duct gallstones
48. Benign surgical disorders of the gallbladder
49. Endoscopic treatment for acute biliary pancreatitis. When and in whom?
50. Endoscopic management of choledocholithiasis: To cut, stretch or relax?
51. Identification of a 130-kilodalton human biliary concanavalin: A binding protein as aminopeptidase N
52. Molecular and micellar associations in the pH-dependent stable and metastable dissolution of unconjugated bilirubin by bile salts
53. Endoscopic retrograde cholangiopancreatography in the management of choledocholithiasis
54. An alternative approach to acute cholecystitis. Percutaneous cholecystostomy and interval laparoscopic cholecystectomy
55. 2955]
56. An update on the pathogenesis and treatment of cholesterol gallstones
57. Etiological and prognostic factors in human acute pancreatitis: A review
58. The prevalence of gallstone disease in very old institutionalized persons
59. Factors associated with successful laparoscopic cholecystectomy for acute cholecystitis
60. Laparoscopic laser cholecystectomy. A comparison with mini-lap cholecystectomy
61. Prevalence of gallstone disease in an Italian adult female population
62. Bile duct injuries, 1989- 993. A statewide experience
63. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: The National Cooperative Gallstone Study. A controlled trial of efficacy and safety
64. Bile acid composition of gallstones from man
65. Diagnosis and treatment of common bile duct stones (CBDS). Results of a consensus development conference
66. Human gallbladder mucin binds biliary lipids and promotes cholesterol crystal nucleation in model bile
67. Endoscopic management of acute gallstone pancreatitis
68. Endoscopic management of choledocholithiasis
69. Acute pancreatitis
70. Laparoscopic biliary surgery
71. Diagnosis of acute cholecystitis by cholescintigraphy: Significance of pericholecystic hepatic uptake
72. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction
73. Predicting gallstone pancreatitis with laboratory parameters: A meta-analysis
74. Pigment vs. cholesterol cholelithiasis: Comparison of stone and bile composition
75. Progress and novel discoveries in biliary tract diseases
76. Gallstones: Choosing the right therapy despite vague clinical clues
77. Causes and management of recurrent biliary pain after successful nonoperative gallstone treatment
78. Investigations on common bile duct stones
79. Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations
80. Medical dissolution therapy of gallstones
81. The pronase resistance of cholesterol-nucleating glycoproteins in human bile